Anti Nuclear Antibodies (ANA)
Immunity0 parametersReport in 4HrsAt Home
No Fasting Required
Details
Antinuclear antibody test screens for autoimmune diseases such as lupus or Sjögren’s syndrome.
₹265₹750
65% OFF
FREE:AI Insights
Anti-Nuclear Antibodies (ANA) Test Information Guide
- Why is it done?
- Detects autoimmune antibodies directed against nuclear antigens within cells, helping identify autoimmune and connective tissue disorders
- Screens for systemic lupus erythematosus (SLE) and other autoimmune diseases when patients present with joint pain, rashes, fever, or fatigue
- Evaluates symptoms suggestive of autoimmune connective tissue disease including Sjögren's syndrome, scleroderma, and mixed connective tissue disease
- Monitors disease activity and treatment response in patients with diagnosed autoimmune conditions
- Typically performed during initial evaluation of unexplained systemic symptoms or when autoimmune disease is clinically suspected
- Normal Range
- Negative or Titer <1:40 (or <1:80 depending on laboratory standards) - considered normal
- Results reported as either negative/positive or as titers (1:40, 1:80, 1:160, 1:320, 1:640, 1:1280, or higher)
- Unit of measurement: Titer (dilution ratio) or qualitative positive/negative result
- Normal result (negative) indicates absence of significant autoimmune activity against nuclear antigens
- Abnormal result (positive) suggests presence of autoimmune disease or autoimmune tendency and requires further investigation
- Low positive titers (1:40-1:80) may have lower clinical significance; moderate to high titers (≥1:160) more strongly correlate with disease
- Interpretation
- Negative ANA: Usually excludes active SLE and most connective tissue diseases; however, does not completely rule out these conditions in all cases
- Positive ANA at 1:40-1:80 (low titer): May be seen in healthy individuals, chronic infections, or mild autoimmune conditions; clinical correlation essential
- Positive ANA at 1:160-1:320 (moderate titer): Significant finding; strongly suggestive of autoimmune disease when accompanied by compatible clinical symptoms
- Positive ANA at ≥1:640 (high titer): Highly suggestive of autoimmune disease; stronger predictor of SLE and related conditions
- Pattern interpretation: Homogeneous pattern (common in SLE), speckled pattern (associated with Sjögren's, mixed connective tissue disease), nucleolar pattern (seen in scleroderma), and peripheral/rim pattern (highly specific for SLE)
- Factors affecting results: Age (higher prevalence in elderly), medications (hydralazine, procainamide, quinidine), infections, malignancy, and smoking status may influence results
- Clinical correlation is essential; positive ANA must be evaluated with patient symptoms, other laboratory findings (complement levels, ESR, CRP), and imaging results for accurate diagnosis
- Persistence of positive ANA over time may indicate chronic autoimmune disease; changing titers may correlate with disease activity in some conditions
- Associated Organs
- Primary organ system: Immune system (produces autoimmune antibodies); secondary involvement includes connective tissues, joints, skin, and multiple organ systems
- Systemic Lupus Erythematosus (SLE): Multisystem disease affecting joints, skin, kidneys, heart, lungs, and blood; ANA positive in 95-98% of SLE cases
- Sjögren's Syndrome: Autoimmune disease targeting salivary and lacrimal glands; ANA positive in 50-80% of cases with associated anti-SSA/Ro and anti-SSB/La antibodies
- Scleroderma (Systemic Sclerosis): Connective tissue disease affecting skin, lungs, heart, and kidneys; ANA positive in 95% of cases, often with anticentromere or anti-Scl-70 antibodies
- Rheumatoid Arthritis: Joint inflammation; ANA positive in 30-50% of cases; more specific markers include rheumatoid factor and anti-CCP antibodies
- Mixed Connective Tissue Disease (MCTD): Overlapping features of SLE, myositis, and scleroderma; ANA positive with characteristic anti-RNP antibodies
- Potential complications: Positive ANA in SLE may indicate risk for lupus nephritis (kidney disease), serositis (pleural/pericardial inflammation), and vasculitis
- Drug-induced lupus: Associated with medications; ANA positive but typically antihistone antibodies; usually reversible upon medication discontinuation
- Follow-up Tests
- ANA panel with specific antibodies: Anti-dsDNA, anti-Smith (anti-Sm), anti-SSA/Ro, anti-SSB/La, anticentromere (ACA), anti-Scl-70, and anti-RNP for disease differentiation
- Complement levels (C3, C4): Decreased levels suggest active SLE and lupus nephritis; assessed to evaluate disease activity and severity
- Complete blood count (CBC): Detects cytopenias (low white blood cells, platelets) common in SLE; may show anemia
- Comprehensive metabolic panel: Assesses kidney and liver function; important in autoimmune diseases with multiorgan involvement
- Urinalysis: Screens for lupus nephritis with proteinuria, hematuria, and RBC casts; essential in SLE monitoring
- Inflammatory markers: Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) to assess systemic inflammation and disease activity
- Rheumatoid factor and anti-CCP antibodies: If rheumatoid arthritis or overlap syndrome suspected
- Imaging studies: Chest X-ray to evaluate pulmonary involvement; kidney ultrasound or biopsy if glomerulonephritis suspected
- Coagulation studies: Assess for antiphospholipid antibodies if thrombosis or recurrent miscarriage history present
- Monitoring frequency: Repeat ANA testing not routinely recommended for monitoring; specific antibodies (anti-dsDNA, complement levels) used instead to assess disease activity
- Fasting Required?
- No, fasting is not required for the ANA test
- Patient can eat and drink normally before blood collection
- No specific medications need to be withheld; continue all regular medications unless otherwise instructed by physician
- Important note: Certain medications (hydralazine, procainamide, quinidine, isoniazid) may cause false-positive results; inform healthcare provider of current medications
- Timing: Blood sample collection can be performed at any time of day; no specific time-of-day requirements
- Patient preparation: Wear loose-fitting clothing to facilitate blood draw; remain calm and relaxed before venipuncture
- No specific restrictions on hydration; adequate fluid intake may help with venipuncture
How our test process works!
